ElyCia Lifesciences

Category: HealthTech / MedTech – Smart Respiratory Care Platform.

Startup Summary 

ElyCia Lifesciences is a healthtech startup developing smart respiratory care solutions. Its flagship product, Inhalebot™, powered by the TBot™ Intelligence Engine, combines connected inhaler technology and data-driven intelligence to improve medication adherence, therapy effectiveness, and respiratory disease management.

First Byline: Reimagining respiratory care through intelligent, connected therapy solutions.

Second Byline: Where smart inhalation meets real-time intelligence for better breathing outcomes.

Highlights 

• Building India’s first integrated respiratory therapy and intelligence platform.

• Combines smart drug delivery, patient monitoring, and AI-driven analytics in a single ecosystem.

• Inhalebot™ enables connected, guided inhalation therapy with adherence tracking.

• TBot™ Intelligence Engine converts patient usage data into actionable clinical insights.

• Developing a deep-tech biomarker sensing program for future respiratory disease screening and triage.

• Focused on addressing India's large and growing burden of asthma, COPD, TB, and chronic respiratory diseases.

Team 

• Dr Ruwise EA (Co-Founder) 

• Dr Aswathy Menon (Co-Founder)

What They Do 

• Develop smart respiratory therapy devices and digital health solutions.

• Enable real-time monitoring of inhaler usage and patient adherence.

• Provide AI-powered respiratory analytics for clinicians and healthcare providers.

• Create connected healthcare infrastructure that bridges patients and clinicians.

• Advance biomarker-based respiratory diagnostics through electrochemical sensor technology.

Pain Points 

• Incorrect inhaler usage leading to poor treatment outcomes.

• Low patient adherence to prescribed respiratory therapies.

• Lack of visibility into patient device usage between consultations.

• Absence of real-time monitoring and data-driven intervention.

• Inefficient clinician-patient feedback loops.

• High rates of preventable hospitalizations due to poor disease management.

• Growing burden of asthma, COPD, and other chronic respiratory diseases in India.

• Limited access to affordable, technology-enabled respiratory care solutions.

Solution 

• Inhalebot™ – IoT-enabled smart inhalation platform for guided therapy delivery and adherence tracking.

• TBot™ Intelligence Engine – AI-powered analytics platform that monitors respiratory behavior and generates actionable clinical insights.

• Clinician Dashboard – Real-time visibility into patient usage patterns, adherence, and therapy effectiveness.

• Automated Adherence System – Smart reminders and monitoring to improve treatment compliance.

• EC Sensor Program – Deep-tech breath biomarker sensing technology for future respiratory screening and triage.

• Integrated Respiratory Intelligence Platform – Combines therapy delivery, patient monitoring, and AI-driven decision support in a single ecosystem.

• Affordable India-First Design – Cost-effective respiratory care solution tailored for large-scale deployment in India.

• Data-Driven Disease Management – Enables continuous patient monitoring and informed clinical interventions.